Merck
  • Home
  • Search Results
  • Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.

Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.

Molecular genetics and metabolism (2013-10-05)
Maureen Cleary, Friedrich Trefz, Ania C Muntau, François Feillet, Francjan J van Spronsen, Alberto Burlina, Amaya Bélanger-Quintana, Maria Giżewska, Christoph Gasteyger, Esther Bettiol, Nenad Blau, Anita MacDonald
ABSTRACT

Fluctuations in blood phenylalanine concentrations may be an important determinant of intellectual outcome in patients with early and continuously treated phenylketonuria (PKU). This review evaluates the studies on phenylalanine fluctuations, factors affecting fluctuations, and if stabilizing phenylalanine concentrations affects outcomes, particularly neurocognitive outcome. Electronic literature searches of Embase and PubMed were performed for English-language publications, and the bibliographies of identified publications were also searched. In patients with PKU, phenylalanine concentrations are highest in the morning. Factors that can affect phenylalanine fluctuations include age, diet, timing and dosing of protein substitute and energy intake, dietary adherence, phenylalanine hydroxylase genotype, changes in dietary phenylalanine intake and protein metabolism, illness, and growth rate. Even distribution of phenylalanine-free protein substitute intake throughout 24h may reduce blood phenylalanine fluctuations. Patients responsive to and treated with 6R-tetrahydrobiopterin seem to have less fluctuation in their blood phenylalanine concentrations than controls. An increase in blood phenylalanine concentration may result in increased brain and cerebrospinal fluid phenylalanine concentrations within hours. Although some evidence suggests that stabilization of blood phenylalanine concentrations may have benefits in patients with PKU, more studies are needed to distinguish the effects of blood phenylalanine fluctuations from those of poor metabolic control.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-苯基丙氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-苯基丙氨酸, reagent grade, ≥98%
Supelco
L-苯基丙氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-苯基丙氨酸, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
L-苯基丙氨酸, 99%
USP
L-苯基丙氨酸, United States Pharmacopeia (USP) Reference Standard
苯丙氨酸, European Pharmacopoeia (EP) Reference Standard
Supelco
L-苯基丙氨酸, certified reference material, TraceCERT®
Supelco
L-苯基丙氨酸, analytical standard, for Nitrogen Determination According to Kjeldahl Method
Sigma-Aldrich
L-苯基丙氨酸, 99%, FCC
SAFC
L-苯基丙氨酸